Status:
ACTIVE_NOT_RECRUITING
Multimodal Epicardial and Endocardial COronary PHYsiological Evaluation in Pathological Situations (PHYCO)
Lead Sponsor:
University Hospital, Brest
Conditions:
Coronary Artery Disease
Coronary Microvascular Dysfunction
Eligibility:
All Genders
18-100 years
Brief Summary
When performing coronary angiography in a stable situation, the identification of an intermediate coronary lesion (between 50 and 70%) is common, and requires additional functional evaluation. The gol...
Eligibility Criteria
Inclusion
- Intermediate coronary lesion (between 50 and 70%)
Exclusion
- Hemodynamic instability
- Adenosine hypersensitivity
- Asthma
- Severe chronic obstructive pulmonary disease
- Long QTc
- Wolff parkinson white
- High degree atriovenricular block
- Left-right shunt
- Carotid artery stenosis with hemodynamic insufficiency
- Pregnancy
Key Trial Info
Start Date :
July 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06008041
Start Date
July 13 2023
End Date
April 1 2027
Last Update
August 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29609